Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

E-LEARNING MODULES

DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

The Top 15 U.S. Pharmacies of 2025: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)

This week, we’re rerunning some popular posts while we prepare for Friday’s live video webinar: 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders. more >

Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight

Today’s guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx’s proprietary data and case studies, Stephen highlights patterns more >